CombiMatrix Corporation Reports 2015 Fourth Quarter and Full Year Financial and Operating Results
February 17, 2016 16:05 ET
|
CombiMatrix Corporation
Revenue Growth of 21% for the Quarter Driven by Record Miscarriage Analysis and Pre-Implantation Genetic Screening Test VolumesConference Call Begins Today at 4:30 p.m. Eastern Time IRVINE, Calif.,...
CombiMatrix Regains Compliance With NASDAQ Minimum Bid Price Listing Requirement
February 17, 2016 06:00 ET
|
CombiMatrix Corporation
IRVINE, Calif., Feb. 17, 2016 (GLOBE NEWSWIRE) -- CombiMatrix Corporation (NASDAQ:CBMX), a molecular diagnostics company specializing in DNA-based testing services for prenatal, miscarriage...
CombiMatrix Comments on Revised Reimbursement Policies for Recurrent Pregnancy Loss
February 11, 2016 06:00 ET
|
CombiMatrix Corporation
IRVINE, Calif., Feb. 11, 2016 (GLOBE NEWSWIRE) -- CombiMatrix Corporation (NASDAQ:CBMX), a molecular diagnostics company specializing in DNA-based testing services for prenatal and postnatal...
CombiMatrix Migrates Miscarriage Analysis Microarray Testing to Newer Scanning Panel
February 09, 2016 06:00 ET
|
CombiMatrix Corporation
IRVINE, Calif., Feb. 09, 2016 (GLOBE NEWSWIRE) -- CombiMatrix Corporation (NASDAQ:CBMX), a molecular diagnostics company specializing in DNA-based testing services for prenatal and postnatal...
CombiMatrix Corporation to Release 2015 Fourth Quarter and Full Year Financial Results on February 17, 2016
February 08, 2016 06:00 ET
|
CombiMatrix Corporation
IRVINE, Calif., Feb. 08, 2016 (GLOBE NEWSWIRE) -- CombiMatrix Corporation (NASDAQ:CBMX) announces that it will release financial results for the three months and full year ended December 31, 2015...
CombiMatrix Study Published in Genetics in Medicine
February 01, 2016 06:00 ET
|
CombiMatrix Corporation
IRVINE, Calif., Feb. 01, 2016 (GLOBE NEWSWIRE) -- CombiMatrix Corporation (NASDAQ:CBMX), a molecular diagnostics company specializing in DNA-based testing services for prenatal and postnatal...
CombiMatrix Announces Commercial Launch of Microarray Testing for Stillbirth Analysis
January 28, 2016 06:00 ET
|
CombiMatrix Corporation
IRVINE, Calif., Jan. 28, 2016 (GLOBE NEWSWIRE) -- CombiMatrix Corporation (NASDAQ:CBMX), a molecular diagnostics company specializing in DNA-based testing services for prenatal, miscarriage...
CombiMatrix Announces 1-for-15 Reverse Split of Common Stock
January 27, 2016 06:00 ET
|
CombiMatrix Corporation
IRVINE, Calif., Jan. 27, 2016 (GLOBE NEWSWIRE) -- CombiMatrix Corporation (NASDAQ:CBMX), a molecular diagnostics company specializing in DNA-based testing services for prenatal, miscarriage...
New Data From Multi-Year Study of Pregnancy Loss Support Efficacy and Diagnostic Power of CombiMatrix’s Chromosomal Microarray Analysis
January 06, 2016 06:00 ET
|
CombiMatrix Corporation
IRVINE, Calif., Jan. 06, 2016 (GLOBE NEWSWIRE) -- CombiMatrix Corporation (NASDAQ:CBMX), a molecular diagnostics company specializing in DNA-based testing services for prenatal, miscarriage analysis...
CombiMatrix Announces Multicycle Offering for Pre-Implantation Genetic Screening and Improved Cost Efficiencies
December 16, 2015 06:00 ET
|
CombiMatrix Corporation
IRVINE, Calif., Dec. 16, 2015 (GLOBE NEWSWIRE) -- CombiMatrix Corporation (NASDAQ:CBMX), a molecular diagnostics company specializing in DNA-based testing services for prenatal, miscarriage...